News

MS Mythbusters: Clinical trials are experimental and I might not benefit from participating

Our series of MS Mythbusters aims to dispel some of the outdated, inaccurate or confusing information you may have heard or read.

This video busts the myth that clinical trials are experimental and you may not benefit from taking part. In fact, there is a wide range of trials which you could benefit from including physiotherapy, psychological interventions, short surveys or clinical trials.

If you would like to find out more about getting involved and participating in research into MS simply follow the links below.

More resources:

ofatumumab autoinjector pen

A reminder about PBS listing changes for REBIF and AVONEX

REBIF (interferon beta-1a) and AVONEX (interferon beta-1a) are currently used for the treatment of Australians living with relapsing forms of MS. Recently, there were some changes announced to their listing on the PBS.
autoinjector-pen

Changes announced to AVONEX listing on PBS

From 1 April 2023, AVONEX will no longer be available on the Pharmaceutical Benefits Scheme (PBS) for Australians living with MS.

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More

Newsletter subscription

  • Enter your details

MS Mythbusters: Clinical trials are experimental and I might not benefit from participating